SCHEMBL4930403

SCHEMBL4930403

CC(=O)Nc1ccc(CNc2c(Nc3ccc4[nH]cnc4c3)c(=O)c2=O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 6/20 0.54
ROCK1 Q13464 6/20 0.54
PRKG1 Q13976 6/20 0.54
CLK4 Q9HAZ1 5/20 0.54
CHEK2 O96017 5/20 0.54
PRKACA P17612 5/20 0.54
RPS6KB1 P23443 5/20 0.54
RPS6KA3 P51812 5/20 0.54
PKN2 Q16513 5/20 0.54
CDC42BPA Q5VT25 5/20 0.54
HIPK4 Q8NE63 5/20 0.54
AURKB Q96GD4 5/20 0.54
ROCK2 O75116 4/20 0.54
CHEK1 O14757 4/20 0.54
PRKCD Q05655 4/20 0.54
MKNK2 Q9HBH9 4/20 0.54
SGK2 Q9HBY8 4/20 0.54
AKT1 P31749 4/20 0.54
MAP4K4 O95819 3/20 0.54
PRKAA1 Q13131 3/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4908255 0.90 AURKB (0.68) GSK3BROCK1PRKG1CLK4CHEK2
SCHEMBL4598260 0.87 ROCK1 (0.47) GSK3BROCK1PRKG1CLK4CHEK2
SCHEMBL4910893 0.87 ROCK1 (0.47) GSK3BROCK1PRKG1CLK4CHEK2
SCHEMBL4908067 0.85 GSK3B (0.44) GSK3BROCK1PRKG1CLK4CHEK2
SCHEMBL14066718 0.85 MAPKAPK2 (0.54) GSK3BROCK1PRKG1CLK4CHEK2
SCHEMBL4904962 0.84 GSK3B (0.47) GSK3BROCK1PRKG1CLK4CHEK2
SCHEMBL4908343 0.83 ROCK1 (0.46) GSK3BROCK1PRKG1CLK4CHEK2
SCHEMBL4905370 0.83 ROCK1 (0.46) GSK3BROCK1PRKG1CLK4CHEK2
SCHEMBL4908588 0.83 QPCT (0.48) GSK3BROCK1PRKG1CLK4CHEK2
SCHEMBL4907453 0.83 ROCK2 (0.54) GSK3BROCK1PRKG1CLK4CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234266-A1 Squaric Acid Derivatives II CHEK2, CHEK1, SGK3 GSK3B 132/4885ROCK1 713/4885PRKG1 1013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.